Profound Medical Corp. PROF
$ 7.24
-0.55%
Annual report 2023
added 12-21-2024
Profound Medical Corp. Balance Sheet 2011-2024 | PROF
Annual Balance Sheet Profound Medical Corp.
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | -7.36 M | -18.7 M | -5.96 M | -10.6 M | -3.37 M | 1.31 M | - | - | - | ||
Long Term Debt |
- | - | - | - | 6.72 M | 10.6 M | 444 K | 2.8 M | 4.01 M | 1.95 M | - | - | - |
Long Term Debt Current |
259 K | 239 K | 250 K | 312 K | 199 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 2.44 M | 9.69 M | 12 M | 3.01 M | 2.91 M | 4.29 M | - | - | - | - |
Total Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
12.7 M | 12.4 M | 6.16 M | 7.25 M | - | - | 13.7 M | 6.59 M | 5.21 M | 103 K | - | - | - |
Deferred Revenue |
- | - | - | 358 K | 655 K | 313 K | 241 K | 193 K | - | - | - | - | - |
Retained Earnings |
- | - | - | -130 M | -131 M | -111 M | -90.3 M | -53.2 M | -39.7 M | -453 K | - | - | - |
Total Assets |
43.9 M | 64.4 M | 86.8 M | 105 M | - | - | 27.9 M | 17.6 M | 15.3 M | 1.47 M | - | - | - |
Cash and Cash Equivalents |
26.2 M | 46.5 M | 67.2 M | 83.9 M | 14.8 M | - | - | - | - | - | - | - | - |
Book Value |
31.2 M | 52 M | 80.6 M | 97.4 M | - | - | 14.1 M | 11 M | 10.1 M | 1.37 M | - | - | - |
Total Shareholders Equity |
- | - | - | 97.4 M | 14.4 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Profound Medical Corp.
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | 1.13 M | - | - | - | 1.36 M | - | - | - | 1.64 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | 6.16 M | - | - | - | 7.25 M | - | - | - | 15.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | - | -161 M | - | - | - | -130 M | - | - | - | -108 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | - | - | - | 86.8 M | - | - | - | 105 M | - | - | - | 30.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | - | - | - | 67.2 M | - | - | - | 83.9 M | - | - | - | 14.8 M | - | - | - | 22.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | - | - | - | 80.6 M | - | - | - | 97.4 M | - | - | - | 14.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | - | - | - | 80.6 M | - | - | - | 97.4 M | - | - | - | 14.4 M | - | - | - | 19.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency